Does Cardinal Health, Inc. (CAH) Stock have a positive outlook following recent trade?

Barclays raised the price target for the Cardinal Health, Inc. (NYSE:CAH) stock to “an Overweight”. The rating was released on January 03, 2024, according to finviz.

Historical Earnings Surprises and Revenue Forecasts

Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock price to increase when earnings exceed market expectations and progressively decrease when earnings do not meet expectations. The firm reported an earnings per share (EPS) of $1.82 during the last quarter as opposed to a consensus estimate of $1.6, which indicates the company beat its estimate by $0.22, which implies that the company surprised the market by 13.70%. It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $1.95. This is an average of 12 analysts’ earnings, where the high earnings per share estimate is $2.01 and the low earnings per share estimate is $1.86. According to 9 analyst estimates, an average revenue estimate of $55.87B is projected for the current quarter with a high revenue estimate of $56.96B and a low estimate of $54.9B.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The latest trade, Performances and Moving Averages give us the following Picture

The firm’s stock price fluctuated -2.25% within the last five trades and -0.62% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 11.70% in the last 6 months and -0.26% was subtracted to its value over the previous 3 months. CAH stock is trading at a margin of -2.60%, -1.90% and 9.24% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

As of the close of trading, CAH deals in the Healthcare domain. The stock is trading -7.78 percent below its 52-week high and 49.91 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is 28.6. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

What Does Cardinal Health, Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?

With regard to the profitability of the company, the operating margin is currently at 0.97 percent and the profit margin is 0.30 percent, and the company has reported a gross margin of 3.25 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.

The stock’s market cap achieved a total value of $24.99 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for Cardinal Health, Inc. (NYSE:CAH) is 40.44. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 12.91. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 0.12 that mirrors the cost to be found for sales by the market.

Is Insider Trading a Real Thing?

Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.63 percent of Cardinal Health, Inc. shares are owned by insiders, and 90.02 percent are held by financial institutions. WEITZMAN DEBORAH, the CEO, Pharmaceutical Segment at Cardinal Health, Inc. (CAH) has sold 36,642 shares of firm on Nov 27 at a price of $106.31 against the total amount of $3.9 million. In another inside trade, WEITZMAN DEBORAH, CEO, Pharmaceutical Segment of Cardinal Health, Inc. (NYSE:CAH) sold 6,712 shares of the firm on Aug 28 for a total worth of $0.6 million at a price of $89.81. An inside trade which took place on Aug 18, Chief Accounting Officer of Cardinal Health, Inc. Scherer Mary C. sold 20,695 shares of firm against total price of $1.79 million at the cost of $86.27 per share.

Most Popular

Related Posts